HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19.

Abstract
SARS-CoV-2 antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.
AuthorsElizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, Kevin O McNerney, Madison E Weirick, Sigrid Gouma, Marcus J Bolton, Claudia P Arevalo, Julie Chase, Philip Hicks, Tomaz B Manzoni, Amy E Baxter, Kurt P Andrea, Chakkapong Burudpakdee, Jessica H Lee, Laura A Vella, Sarah E Henrickson, Rebecca M Harris, E John Wherry, Paul Bates, Hamid Bassiri, Edward M Behrens, David T Teachey, Scott E Hensley
JournalmedRxiv : the preprint server for health sciences (medRxiv) (Aug 18 2020) United States
PMID32839782 (Publication Type: Preprint)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: